Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2025
Mar. 31, 2024
Current assets:    
Cash and cash equivalents $ 562.7 $ 365.0
Restricted cash and cash equivalents 5.0 5.0
Restricted cash and cash equivalents - Asbestos 37.9 45.8
Restricted short-term investments - Asbestos 175.8 178.4
Accounts and other receivables, net 391.8 366.1
Inventories 347.1 337.8
Prepaid expenses and other current assets 100.6 68.2
Assets held for sale 73.1 55.4
Insurance receivable - Asbestos 5.5 5.1
Workers’ compensation - Asbestos 2.3 1.6
Total current assets 1,701.8 1,428.4
Property, plant and equipment, net 2,169.0 2,037.8
Operating lease right-of-use-assets 70.4 60.9
Goodwill 193.7 192.6
Intangible assets, net 145.6 149.2
Insurance receivable - Asbestos 23.2 26.4
Workers’ compensation - Asbestos 16.5 13.6
Deferred income taxes 600.4 690.4
Deferred income taxes - Asbestos 284.5 294.0
Other assets 24.8 19.3
Total assets 5,229.9 4,912.6
Current liabilities:    
Accounts payable and accrued liabilities 446.4 463.3
Accrued payroll and employee benefits 133.3 143.3
Operating lease liabilities 21.6 19.0
Long-term debt, current portion 9.4 7.5
Accrued product warranties 7.3 7.3
Income taxes payable 10.3 13.0
Asbestos liability 119.4 116.7
Workers’ compensation - Asbestos 2.3 1.6
Other liabilities 60.2 26.0
Total current liabilities 810.2 797.7
Long-term debt 1,110.1 1,115.1
Deferred income taxes 121.1 107.5
Operating lease liabilities 63.9 59.4
Accrued product warranties 26.9 28.9
Asbestos liability 864.2 873.0
Workers’ compensation - Asbestos 16.5 13.6
Other liabilities 55.5 58.5
Total liabilities 3,068.4 3,053.7
Commitments and contingencies (Note 14)
Shareholders’ equity:    
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 429,818,781 shares issued and outstanding at 31 March 2025 and 433,784,634 shares issued and outstanding at 31 March 2024 222.1 224.7
Additional paid-in capital 271.9 256.5
Retained earnings 1,725.7 1,446.0
Accumulated other comprehensive loss (58.2) (68.3)
Total shareholders’ equity 2,161.5 1,858.9
Total liabilities and shareholders’ equity $ 5,229.9 $ 4,912.6